Skip to main content

and
  1. Article

    Open Access

    Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohort

    Advances in therapy of metastatic castration-refractory prostate cancer (mCRPC) resulted in more therapeutic options and led to a higher need of predictive/prognostic biomarkers. Systemic inflammatory biomarke...

    Manuel Neuberger, Nora Goly, Janina Skladny in Journal of Cancer Research and Clinical On… (2023)